Morphine alters the locomotor responses to a D2/D3 dopamine receptor agonist differentially in adolescent and adult mice

Journal of Psychopharmacology

Volumn 26, Issue 10, 2012, Pages 1355-1365

  Hofford, Rebecca S ^a   Wellman, Paul J ^a   Eitan, Shoshana ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

age dependent; drugs of abuse; locomotion; opioid; Quinpirole; SKF 38393; withdrawal

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; MORPHINE; QUINPIROLE;

ADOLESCENT; AGE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR MODIFICATION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG SCREENING; EVOKED RESPONSE; LOCOMOTION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AGING; ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM; DOPAMINE AGONISTS; DOPAMINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERKINESIS; MALE; MICE; MICE, INBRED C57BL; MORPHINE DEPENDENCE; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; PRESYNAPTIC TERMINALS; QUINPIROLE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84866258747     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112443741     Document Type: Article

References (81)

1. Anraku T, Ikegaya Y, Matsuki N, et al. Withdrawal from chronic morphine administration causes prolonged enhancement of immobility in rat forced swimming test. Psychopharmacology (Berl). 2001 ; 157: 217-220
2. Ashby CR, Paul M, Gardner EL, et al. Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats. Synapse. 2003 ; 48: 154-156
3. Bassareo V, Tanda G, Di Chiara G. Increase of extracellular dopamine in the medial prefrontal cortex during spontaneous and naloxone-precipitated opiate abstinence. Psychopharmacology (Berl). 1995 ; 122: 202-205
4. Basso AM, Gallagher KB, Bratcher NA, et al. Antidepressant-like effect of D2/3 receptor-, but not D4 receptor-activation in the rat Forced Swim Test. Neuropsychopharmacology. 2005 ; 30: 1257-1268
5. Beaulieu J-M, Gainetdinov RR. The Physiology, signaling, and pharmacology of dopamine receptors. Pharm Rev. 2011 ; 63: 182-217
6. Becker WC, Sullivan LE, Tetrault JM, et al. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008 ; 94: 38-47
7. Benes FM, Taylor JB, Cunningham MC. Convergence and plasticity of monoaminergic systems in the medial prefrontal cortex during the postnatal period: implications for the development of psychopathology. Cereb. Cortex. 2000 ; 10: 1014-1027
8. Blum K, Noble EP, Sheridan PJ, et al. Association of the A1 allele of the D2 dopamine receptor gene with severe alcoholism. Alcohol. 1991 ; 8: 409-416
9. Brocco M, Dekeyne A, Papp M, et al. Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors. Behav Pharmacol. 2006 ; 17: 559-572
10. Buckman SG, Hodgson SR, Hofford RS, et al. Increased elevated plus maze open-arm time in mice during spontaneous morphine withdrawal. Behav Brain Res. 2009 ; 197: 454-456
11. Busto UE, Sproule BA, Knight K, et al. Severe dependence in oral opioids. Can. J. Clin. Pharmacol. 1998 ; 5: 23-28
12. Campbell JO, Wood RD, Spear LP. Cocaine and morphine-induced place conditioning in adolescent and adult rats. Physiol Behav. 2000 ; 68: 487-493
13. Contet C, Filliol D, Matifas A, et al. Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity. Neuropharmacology. 2008 ; 54: 475-486
14. Cook CD, Barrett AC, Syvanthong C, et al. The dopamine D3/2 agonist 7-OH-DPAT attenuates the development of morphine tolerance but not physical dependence in rats. Psychopharmacology (Berl). 2000 ; 152: 93-104
15. Cook CD, Beardsley PM. The modulatory actions of dopamine D2/3 agonists and antagonists on the locomotor-activating effects of morphine and caffeine in mice. Pharmacol Biochem Behav. 2003 ; 75: 363-371
16. De Vries TJ, Schoffelmeer AN, Binnekade R, et al. Dopaminergic mechanisms mediating the incentive to seek cocaine and heroin following long-term withdrawal of IV drug self-administration. Psychopharmacology (Berl). 1999 ; 143: 254-260
17. Dockstader CL, Rubinstein M, Grandy DK, et al. The D2 receptor is critical in mediating opiate motivation only in opiate-dependent and withdrawn mice. Eur J Neurosci. 2001 ; 13: 995-1001
18. Dowling K, Storr CL, Chilcoat HD. Potential influences on initiation and persistence of nonmedical prescription pain reliever use in the US population. Clin. J. Pain. 2006 ; 22: 776-783
19. Druhan JP, Walters CL, Aston-Jones G. Behavioral activation induced by D2-like receptor stimulation during opiate withdrawal. J Pharmacol Exp Ther. 2000 ; 294: 531-538
20. Eitan S, Bryant CD, Saliminejad N, et al. Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization. J Neurosci. 2003 ; 23: 8360-8369
21. el-kadi AO, Sharif SI. The influence of various experimental conditions on the expression of naloxone-induced withdrawal symptoms in mice. Gen Pharmacol. 1994 ; 25: 1505-1510
22. Elmer GI, Pieper JO, Rubinstein M, et al J Neurosci. RC224 ; 2002
23. Elwan MA, Soliman MR. Alteration of D1 and D2 dopaminergic receptor kinetics in specific rat brain regions following repeated administration of opiates. Pharmacology. 1995 ; 51: 73-83
24. Esposito-Smythers C, Spirito A, Rizzo C, et al. Associations of the DRD2 TaqIA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents. Pharmacol Biochem Behav. 2009 ; 93: 306-312
25. Frances H, Smirnova M, Leriche L, et al. Dopamine D3 receptor ligands modulate the acquisition of morphine-conditioned place preference. Psychopharmacology (Berl). 2004 ; 175: 127-133
26. Funada M, Shippenberg TS. Differential involvement of D1 and D2 dopamine receptors in the expression of morphine withdrawal signs in rats. Behav Pharmacol. 1996 ; 7: 448-453
27. Georges F, Stinus L, Bloch B, et al. Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur J Neurosci. 1999 ; 11: 481-490
28. Gershon AA, Vishne T, Grunhaus L. Dopamine D2-like receptors and the antidepressant response. Biol Psychiatry. 2007 ; 61: 145-153
29. Giedd JN. Structural magnetic resonance imaging of the adolescent brain. Ann N Y Acad Sci. 2004 ; 1021: 77-85
30. Gogtay N, Giedd JN, Lusk L, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A. 2004 ; 101: 8174-8179
31. Halberda JP, Middaugh LD, Gard BE, et al. DAD1- and DAD2-like agonist effects on motor activity of C57 mice: differences compared to rats. Synapse. 1997 ; 26: 81-92
32. Handal M, Grung M, Skurtveit S, et al. Pharmacokinetic differences of morphine and morphine-glucuronides are reflected in locomotor activity. Pharmacol Biochem Behav. 2002 ; 73: 883-892
33. Handelsman L, Aronson MJ, Ness R, et al. The dysphoria of heroin addiction. Am J Drug Alcohol Abuse. 1992 ; 18: 275-287
34. Harris GC, Aston-Jones G. Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature. 1994 ; 371: 155-157
35. Hodgson SR, Hofford RS, Wellman PJ, et al. Different affective response to opioid withdrawal in adolescent and adult mice. Life Sci. 2009 ; 84: 52-60
36. Ingram SL, Fossum EN, Morgan MM. Behavioral and electrophysiological evidence for opioid tolerance in adolescent rats. Neuropsychopharmacology. 2007 ; 32: 600-606
37. Kest B, Palmese CA, Hopkins E, et al. Assessment of acute and chronic morphine dependence in male and female mice. Pharmacol Biochem Behav. 2001 ; 70: 149-156
38. Koshibu K, Levitt P, Ahrens ET. Sex-specific, postpuberty changes in mouse brain structures revealed by three-dimensional magnetic resonance microscopy. NeuroImage. 2004 ; 22: 1636-1645
39. Laschka E, Herz A, Bläsig J. Activity of the nigro-striatal dopaminergic system during precipitated morphine withdrawal investigated in rats with acute unilateral inactivation of the striatum. Naunyn Schmiedebergs Arch Pharmacol. 1976 ; 296: 15-23
40. Lee JM, DeLeon-Jones F, Fields JZ, et al. Cyclo (Leu-Gly) attenuates the striatal dopaminergic supersensitivity induced by chronic morphine. Alcohol Drug Res. 1987 ; 7: 1-10
41. Leslie CA, Robertson MW, Cutler AJ, et al. Postnatal development of D1 dopamine receptors in the medial prefrontal cortex, striatum and nucleus accumbens of normal and neonatal 6-hydroxydopamine treated rats: a quantitative autoradiographic analysis. Brain Res Dev Brain Res. 1991 ; 62: 109-114
42. Li SM, Collins GT, Paul NM, et al. Yawning and locomotor behavior induced by dopamine receptor agonists in mice and rats. Behav Pharmacol. 2010a ; 21: 171-181
43. Li T, Hou Y, Yan CX, et al. Dopamine D3 receptor knock-out mice display deficits in locomotor sensitization after chronic morphine administration. Neurosci Lett. 2010b ; 485: 256-260
44. Maldonado R, Saiardi A, Valverde O, et al. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature. 1997 ; 388: 586-589
45. Marsteller DA, Gerald CPG, Kong R, et al. The MCH1 receptor antagonist SNAP 94847 induces sensitivity to dopamine D2/D3 receptor agonists in rats and mice. Eur J Pharmacol. 2009 ; 602: 66-72
46. Martins SS, Keyes KM, Storr CL, et al. Pathways between nonmedical opioid use/dependence and psychiatric disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 2009 ; 103: 16-24
47. Millan MJ, Seguin L, Gobert A, et al. The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: a combined behavioural and neurochemical analysis with novel, selective antagonists in rats. Psychopharmacology. 2004 ; 174: 341-357
48. Mogenson GJ, Wu M. Effects of administration of dopamine D2 agonist quinpirole on exploratory locomotion. Brain Res. 1991 ; 551: 216-220
49. Montague DM, Lawler CP, Mailman RB, et al. Developmental regulation of the dopamine D1 receptor in human caudate and putamen. Neuropsychopharmacology. 1999 ; 21: 641-649
50. Narita M, Mizuo K, Mizoguchi H, et al. Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion. J Neurosci. 2003 ; 23: 1006-1012
51. Navarro M, Fernández-Ruiz JJ, Rodriguez De, Fonseca F, et al. Modifications of striatal D2 dopaminergic postsynaptic sensitivity during development of morphine tolerance-dependence in mice. Pharmacol Biochem Behav. 1992 ; 43: 603-608
52. Nemoda Z, Szekely A, Sasvari-Szekely M. Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood. Neurosci Biobehav Rev. 2011 ; 35: 1665-1686
53. Nozaki M, Akera T, Lee CY, et al. The effects of age on the development of tolerance to and physical dependence on morphine in rats. J Pharmacol Exp Ther. 1975 ; 192: 506-512
54. The Partnership Attitude Tracking Study (PATS). New York, NY: Partnership for a Drug-Free America ; 2009
55. Piepponen TP, Katajamäki J, Kivastik T, et al. Behavioural and neurochemical sensitization of morphine-withdrawn rats to quinpirole. Pharmacol Biochem Behav. 1996 ; 54: 787-792
56. Reddy PL, Veeranna , Thorat SN, et al. Evidence for the behavioral supersensitivity of dopamine D2 receptors without receptor up-regulation in morphine-abstinent rats. Brain Res. 1993 ; 607: 293-300
57. Rosenblum A, Joseph H, Fong C, et al. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003 ; 289: 2370-2378
58. Ross SB, Jackson DM, Wallis EM, et al. Enhancement by a single dose of reserpine (plus alpha methyl-p-tyrosine) of the central stimulatory effects evoked by dopamine D-1 and D-2 agonists in the mouse. Naunyn Schmiedebergs Arch Pharmacol. 1988 ; 337: 512-518
59. Rouge-Pont F, Usiello A, Benoit-Marand M, et al. Changes in extracellular dopamine induced by morphine and cocaine: crucial control by D2 receptors. J Neurosci. 2002 ; 22: 3293-3301
60. Substance Abuse and Mental Health Services Administration OoAS. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies ; 2009
61. Sanberg PR, Zoloty SA, Willis R, et al. Digiscan activity: automated measurement of thigmotactic and stereotypic behavior in rats. Pharmacol Biochem Behav. 1987 ; 27: 569-572
62. Seeman P. All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors. CNS Neurosci Ther. 2011 ; 17: 118-132
63. Shobe FO, Brion P. Long-term prognosis in manic-depressive illness. Arch Gen Psychiatry. 1971 ; 24: 334-337
64. Siuciak JA, Fujiwara RA. The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors. Psychopharmacology. 2004 ; 175: 163-169
65. Smith JW, Fetsko LA, Xu R, et al. Dopamine D2L receptor knockout mice display deficits in positive and negative reinforcing properties of morphine and in avoidance learning. Neuroscience. 2002 ; 113: 755-765
66. Sowell ER, Thompson PM, Holmes CJ, et al. In vivo evidence for post-adolescent brain maturation in frontal and striatal regions. Nat Neurosci. 1999 ; 2: 859-861
67. Spear LP. The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev. 2000 ; 24: 417-463
68. Spear LP, Horowitz GP, Lipovsky J. Altered behavioral responsivity to morphine during the periadolescent period in rats. Behav Brain Res. 1982 ; 4: 279-288
69. Starke K, Gothert M, Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev. 1989 ; 69: 864-989
70. Starr BS, Starr MS, Kilpatrick IC. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse. Neuroscience. 1987 ; 22: 179-188
71. Sullivan MD, Edlund MJ, Steffick D, et al. Regular use of prescribed opioids: Association with common psychiatric disorders. Pain. 2005 ; 119: 95-103
72. Svestka J. Treatment of bipolar depression. Neuro Endocrinol Lett. 2005 ; 1: 27-47
73. Tetrault JM, Desai RA, Becker WC, et al. Gender and non-medical use of prescription opioids: results from a national US survey. Addiction. 2008 ; 103: 258-268
74. Tokuyama S, Wakabayashi H, Hoskins B, et al. Naloxone-precipitated changes in biogenic amines and their metabolites in various brain regions of butorphanol-dependent rats. Pharmacol Biochem Behav. 1996 ; 54: 461-468
75. Usiello A, Baik J-H, Rouge-Pont F, et al. Distinct functions of the two isoforms of dopamine D2 receptors. Nature. 2000 ; 408: 199-203
76. Wang X, Liu Y, Lei Y, et al. Extremely low-frequency electromagnetic field exposure during chronic morphine treatment strengthens downregulation of dopamine D2 receptors in rat dorsal hippocampus after morphine withdrawal. Neurosci Lett. 2008 ; 433: 178-182
77. Wang Y, Xu R, Sasaoka T, et al. Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions. J Neurosci. 2000 ; 20: 8305-8314
78. Wellman PJ, Davis KW, Clifford PS, et al. Changes in feeding and locomotion induced by amphetamine analogs in rats. Drug Alcohol Depend. 2009 ; 100: 234-239
79. White DA, Michaels CC, Holtzman SG. Periadolescent male but not female rats have higher motor activity in response to morphine than do adult rats. Pharmacol Biochem Behav. 2008 ; 89: 188-199
80. Xu R, Hranilovic D, Fetsko LA, et al. Dopamine D2S and D2L receptors may differentially contribute to the actions of antipsychotic and psychotic agents in mice. Mol Psychiatry. 2002 ; 7: 1075-1082
81. Zheng X, Ke X, Tan B, et al. Susceptibility to morphine place conditioning: relationship with stress-induced locomotion and novelty-seeking behavior in juvenile and adult rats. Pharmacol Biochem Behav. 2003 ; 75: 929-935